CD36 and prostate carcinoma: Among the signaling pathways that have been identified downstream of CD36 in various cell types, the calcium signaling pathway characterized in the context of the murine gustatory perception [28] appears especially relevant, because it involves the ORAI1/3 heterodimer that determines the oncogenic switch in prostate cancer [29].